OASYS NOW, founded by Nima Salami and Sara Okhuijsen, aims to streamline patient recruitment for clinical trials using AI, addressing inefficiencies that impact drug development.
By automating the matching process, OASYS NOW serves as a lifeline for patients with chronic diseases, significantly increasing their chances of accessing critical treatments faster.
The victory at Slush 100 not only brings €1M in investment but also offers OASYS NOW invaluable mentorship from leaders in the healthcare and tech industries.
The current manual process in identifying suitable candidates for clinical trials costs drug research organisations millions and unfortunately leads to lost opportunities for patients.
Collection
[
|
...
]